Mineralys Therapeutics Inc. logo

Mineralys Therapeutics Inc.

MLYS | NASDAQ
Chart Builder DCF Calculator
$28.31
+$0.29 (+1.03%)
At close: Sep 21, 2026, 4:00 PM ET
$28.74
+$0.43 (+1.52%)
Pre-market: Sep 22, 2026, 7:21 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
172.92M 114.09M 49.3M 87.7M 10.61M 1.41M
Short-Term Investments
483.71M 84.1M 187.26M 22.41M n/a n/a
Long-Term Investments
n/a n/a 2.48M n/a n/a n/a
Other Long-Term Assets
382K 499K 51K 1.63M 3K 20K
Receivables
n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
4.75M 7.16M 12.54M 2.7M 50K n/a
Total Current Assets
661.39M 205.35M 249.1M 112.81M 11.12M 1.47M
Property-Plant & Equipment
38K 53K n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
420K 552K 2.53M 1.63M 3K 20K
Total Assets
661.81M 205.9M 251.64M 114.44M 11.13M 1.49M
Account Payables
2.02M 479K 601K 1.91M 763K 529K
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a 4.5M
Other Current Liabilities
7.56M 3.58M 1.6M 665K 313K n/a
Total Current Liabilities
15.11M 14.65M 10.48M 8.07M 5.05M 5.08M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 158.64M 29M n/a
Total Long-Term Liabilities
n/a n/a n/a 158.64M 29M n/a
Total Liabilities
15.11M 14.65M 10.48M 166.71M 34.05M 5.08M
Total Debt
n/a n/a n/a n/a n/a 4.5M
Book Value
646.69M 191.26M 241.15M -52.27M -22.93M -3.6M
Book Value Per Share
9.56 3.94 6.66 -10.12 -4.60 -0.78
Common Stock
8K 5K 4K 1K 1K 1K
Retained Earnings
-457.17M -302.52M -124.71M -52.81M -23.01M -3.6M
Comprehensive Income
n/a n/a -251.64M n/a n/a n/a
Shareholders Equity
646.69M 191.26M 241.15M -52.27M -22.93M -3.6M
Total Investments
483.71M 84.1M 189.75M 22.41M n/a n/a

© 2026 bestshares.com. All rights reserved.